Aberrant neurofilament phosphorylation in Alzheimer disease.

PubWeight™: 2.96‹?› | Rank: Top 1%

🔗 View Article (PMC 397980)

Published in Proc Natl Acad Sci U S A on June 01, 1985

Authors

N H Sternberger, L A Sternberger, J Ulrich

Articles citing this

Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc Natl Acad Sci U S A (1986) 6.56

Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. EMBO J (1985) 6.24

Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (tau) Proc Natl Acad Sci U S A (1986) 4.26

Processing of Alzheimer beta/A4 amyloid precursor protein: modulation by agents that regulate protein phosphorylation. Proc Natl Acad Sci U S A (1990) 2.41

cDNA cloning of human DNA topoisomerase I: catalytic activity of a 67.7-kDa carboxyl-terminal fragment. Proc Natl Acad Sci U S A (1988) 2.38

Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state. EMBO J (1992) 2.16

Recognition of Alzheimer paired helical filaments by monoclonal neurofilament antibodies is due to crossreaction with tau protein. Proc Natl Acad Sci U S A (1987) 1.98

Recognition of tau epitopes by anti-neurofilament antibodies that bind to Alzheimer neurofibrillary tangles. Proc Natl Acad Sci U S A (1987) 1.96

Alzheimer's paired helical filaments share epitopes with neurofilament side arms. EMBO J (1986) 1.81

Phosphorylation on carboxyl terminus domains of neurofilament proteins in retinal ganglion cell neurons in vivo: influences on regional neurofilament accumulation, interneurofilament spacing, and axon caliber. J Cell Biol (1994) 1.67

Alzheimer's neurofibrillary tangles contain unique epitopes and epitopes in common with the heat-stable microtubule associated proteins tau and MAP2. Am J Pathol (1987) 1.66

Molecular analysis of neurofibrillary degeneration in Alzheimer's disease. An immunohistochemical study. Am J Pathol (1990) 1.64

Filaments of Lewy bodies contain insoluble cytoskeletal elements. Am J Pathol (1992) 1.55

cdc2-like kinase from rat spinal cord specifically phosphorylates KSPXK motifs in neurofilament proteins: isolation and characterization. Proc Natl Acad Sci U S A (1993) 1.50

Tau in Alzheimer neurofibrillary tangles. N- and C-terminal regions are differentially associated with paired helical filaments and the location of a putative abnormal phosphorylation site. Biochem J (1991) 1.42

Purkinje cell injury, structural plasticity and fusion in patients with Friedreich's ataxia. Acta Neuropathol Commun (2016) 1.38

Alzheimer disease tangles share immunological similarities with multiphosphorylation repeats in the two large neurofilament proteins. Proc Natl Acad Sci U S A (1988) 1.35

Phosphorylation-dependent epitopes of neurofilament antibodies on tau protein and relationship with Alzheimer tau. Proc Natl Acad Sci U S A (1992) 1.26

Retinal ganglion cell loss in a rat ocular hypertension model is sectorial and involves early optic nerve axon loss. Invest Ophthalmol Vis Sci (2011) 1.24

Calpain mediates calcium-induced activation of the erk1,2 MAPK pathway and cytoskeletal phosphorylation in neurons: relevance to Alzheimer's disease. Am J Pathol (2004) 1.24

Phosphorylated high molecular weight neurofilament protein in lower motor neurons in amyotrophic lateral sclerosis and other neurodegenerative diseases involving ventral horn cells. Acta Neuropathol (1990) 1.19

Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome. Am J Pathol (1990) 1.17

Axonal outgrowth and dendritic plasticity in the cortical peri-infarct area after experimental stroke. Stroke (2012) 1.15

Phosphoproteomic analysis of human brain by calcium phosphate precipitation and mass spectrometry. J Proteome Res (2008) 1.13

Phosphoproteomic analysis reveals site-specific changes in GFAP and NDRG2 phosphorylation in frontotemporal lobar degeneration. J Proteome Res (2010) 1.10

Deregulated Cdk5 activity is involved in inducing Alzheimer's disease. Arch Med Res (2012) 1.08

An antibody against phosphorylated neurofilaments identifies a subset of damaged association axons in Alzheimer's disease. Am J Pathol (1993) 1.06

An immunocytochemical comparison of cytoskeletal proteins in aluminum-induced and Alzheimer-type neurofibrillary tangles. Acta Neuropathol (1986) 1.04

Regulation between O-GlcNAcylation and phosphorylation of neurofilament-M and their dysregulation in Alzheimer disease. FASEB J (2007) 1.04

A truncated peptide from p35, a Cdk5 activator, prevents Alzheimer's disease phenotypes in model mice. FASEB J (2012) 1.03

Direct evidence of phosphorylated neuronal intermediate filament proteins in neurofibrillary tangles (NFTs): phosphoproteomics of Alzheimer's NFTs. FASEB J (2011) 1.02

Topoisomerase I activity associated with human immunodeficiency virus (HIV) particles and equine infectious anemia virus core. EMBO J (1990) 1.02

Alzheimer dementia and Pick's disease: neurofibrillary tangles and Pick bodies are associated with identical phosphorylated neurofilament epitopes. Acta Neuropathol (1987) 0.97

Abnormal processing of multiple proteins in Alzheimer disease. Proc Natl Acad Sci U S A (1989) 0.97

Dysregulation of protein phosphorylation/dephosphorylation in Alzheimer's disease: a therapeutic target. J Biomed Biotechnol (2006) 0.96

Quantitative phosphoproteomic analysis of neuronal intermediate filament proteins (NF-M/H) in Alzheimer's disease by iTRAQ. FASEB J (2010) 0.95

Phosphorylation of neurofilaments is altered in aluminium intoxication. Acta Neuropathol (1986) 0.94

Inhibition of Pin1 reduces glutamate-induced perikaryal accumulation of phosphorylated neurofilament-H in neurons. Mol Biol Cell (2007) 0.94

The phosphorylation state of the microtubule-associated protein tau as affected by glutamate, colchicine and beta-amyloid in primary rat cortical neuronal cultures. Biochem J (1995) 0.93

Immunochemical demonstration of tropomyosin in the neurofibrillary pathology of Alzheimer's disease. Am J Pathol (1990) 0.93

Neurofilament tail phosphorylation: identity of the RT-97 phosphoepitope and regulation in neurons by cross-talk among proline-directed kinases. J Neurochem (2008) 0.93

Sigma-1 receptor regulates Tau phosphorylation and axon extension by shaping p35 turnover via myristic acid. Proc Natl Acad Sci U S A (2015) 0.93

Topographic regulation of neuronal intermediate filaments by phosphorylation, role of peptidyl-prolyl isomerase 1: significance in neurodegeneration. Histochem Cell Biol (2013) 0.90

Neurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam. Immunochemical characterization of tau proteins. Am J Pathol (1995) 0.89

Resolution and purification of a neurofilament-specific kinase. Proc Natl Acad Sci U S A (1989) 0.88

On the biology of prions. Acta Neuropathol (1987) 0.87

Declining phosphatases underlie aging-related hyperphosphorylation of neurofilaments. Neurobiol Aging (2009) 0.87

Progressive supranuclear palsy with hypertrophy of the olives. An immunocytochemical study of the cytoskeleton of argyrophilic neurons. Acta Neuropathol (1988) 0.86

Peptidyl-prolyl isomerase 1 regulates protein phosphatase 2A-mediated topographic phosphorylation of neurofilament proteins. J Neurosci (2009) 0.86

Alzheimer disease and amyotrophic lateral sclerosis: an etiopathogenic connection. Acta Neuropathol (2013) 0.84

Quantitative phosphoproteomics of Alzheimer's disease reveals cross-talk between kinases and small heat shock proteins. Proteomics (2014) 0.83

Altered phosphorylation of tau protein in heat-shocked rats and patients with Alzheimer disease. Proc Natl Acad Sci U S A (1991) 0.83

Neurofilament and glial alterations in the cerebral cortex in amyotrophic lateral sclerosis. Acta Neuropathol (1992) 0.82

Lhermitte-Duclos disease. An immunohistochemical study of the cerebellar cortex. Acta Neuropathol (1988) 0.81

Activation of a neurofilament kinase, a tau kinase, and a tau phosphatase by decreased ATP levels in nerve growth factor-differentiated PC-12 cells. Proc Natl Acad Sci U S A (1995) 0.81

Loss of neurofilament labeling in the primary visual cortex of monocularly deprived monkeys. Cereb Cortex (2004) 0.81

Age-related accumulation of amyloid inclusions in adrenal cortical cells. Am J Pathol (1990) 0.79

Increased in vitro phosphorylation of a Mr 60,000 protein in brain from patients with Alzheimer disease. Proc Natl Acad Sci U S A (1986) 0.79

Hyperphosphorylation and accumulation of neurofilament proteins in transgenic mice with Alzheimer presenilin 1 mutation. Cell Mol Neurobiol (2009) 0.78

A neuronal death model: overexpression of neuronal intermediate filament protein peripherin in PC12 cells. J Biomed Sci (2012) 0.78

Tau pathology generated by overexpression of tau. Am J Pathol (1999) 0.77

Conformational properties of interacting neurofilaments: Monte Carlo simulations of cylindrically grafted apposing neurofilament brushes. J Biol Phys (2012) 0.77

Attenuation of okadaic acid-induced hyperphosphorylation of cytoskeletal proteins by heat preconditioning and its possible underlying mechanisms. Cell Stress Chaperones (2004) 0.76

Expression in cultured human neuroblastoma cells of epitopes associated with affected neurons in Alzheimer's disease. Am J Pathol (1990) 0.76

Immune electron microscopic characterization of monoclonal antibodies to Alzheimer neurofibrillary tangles. Am J Pathol (1992) 0.75

Specialized roles of neurofilament proteins in synapses: Relevance to neuropsychiatric disorders. Brain Res Bull (2016) 0.75

Expression of neurofilament proteins in the vestibular ganglion cells of the rat. Eur Arch Otorhinolaryngol (1990) 0.75

Immunohistochemical and histopathologic correlates of Alzheimer's disease-associated Alz-50 immunoreactivity quantified in homogenates of cerebral tissue. Am J Pathol (1992) 0.75

Refined phosphopeptide enrichment by phosphate additive and the analysis of human brain phosphoproteome. Proteomics (2014) 0.75

Alzheimer's disease--neuropathological aspects. Can J Vet Res (1990) 0.75

Articles cited by this

The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes. J Histochem Cytochem (1970) 20.22

Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ. Proc Natl Acad Sci U S A (1983) 6.14

Alzheimer's disease: insolubility of partially purified paired helical filaments in sodium dodecyl sulfate and urea. Science (1982) 5.42

Monoclonal antibodies show that neurofibrillary tangles and neurofilaments share antigenic determinants. Nature (1982) 4.93

Paired helical filaments from Alzheimer disease patients contain cytoskeletal components. Proc Natl Acad Sci U S A (1985) 2.86

Multiple phosphorylation sites in mammalian neurofilament polypeptides. J Biol Chem (1982) 2.34

Alzheimer's disease: immunoreactivity of neurofibrillary tangles with anti-neurofilament and anti-paired helical filament antibodies. Brain Res (1984) 1.98

Ultrastructure of paired helical filaments of Alzheimer's neurofibrillary tangle. J Neuropathol Exp Neurol (1984) 1.86

Neurotypy: regional individuality in rat brain detected by immunocytochemistry with monoclonal antibodies. Proc Natl Acad Sci U S A (1982) 1.82

Developmental expression of neurotypy revealed by immunocytochemistry with monoclonal antibodies. J Neuroimmunol (1982) 1.48

Immunocytochemistry of brain-reactive monoclonal antibodies in peripheral tissues. Cell Tissue Res (1983) 1.45

Articles by these authors

The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes. J Histochem Cytochem (1970) 20.22

Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ. Proc Natl Acad Sci U S A (1983) 6.14

Monoclonal antibodies show that neurofibrillary tangles and neurofilaments share antigenic determinants. Nature (1982) 4.93

Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J (1989) 4.04

Myelin-associated glycoprotein demonstrated immunocytochemically in myelin and myelin-forming cells of developing rat. Proc Natl Acad Sci U S A (1979) 1.97

Immunocytochemical method to identify basic protein in myelin-forming oligodendrocytes of newborn rat C.N.S. J Neurocytol (1978) 1.94

Immunoperoxidase technics in diagnostic pathology. Report of a workshop sponsored by the National Cancer Institute. Am J Clin Pathol (1979) 1.84

Neurotypy: regional individuality in rat brain detected by immunocytochemistry with monoclonal antibodies. Proc Natl Acad Sci U S A (1982) 1.82

Alzheimer changes in nondemented patients younger than sixty-five: possible early stages of Alzheimer's disease and senile dementia of Alzheimer type. Ann Neurol (1985) 1.75

Myelin basic protein demonstrated immunocytochemically in oligodendroglia prior to myelin sheath formation. Proc Natl Acad Sci U S A (1978) 1.74

A special type of senile plaque, possibly an initial stage. Acta Neuropathol (1987) 1.73

Some photochemical properties of chloroplast preparations from the chrysomonad Hymenomonas sp. Biochim Biophys Acta (1966) 1.72

The unlabeled antibody method. Contrasting color staining of paired pituitary hormones without antibody removal. J Histochem Cytochem (1979) 1.72

Neuritic plaques in senile dementia of Alzheimer type: a Golgi analysis in the hippocampal region. Brain Res (1983) 1.60

Reaction of Lewy bodies with antibodies to phosphorylated and non-phosphorylated neurofilaments. Neurosci Lett (1986) 1.53

Microheterogeneity ("neurotypy") of neurofilament proteins. Proc Natl Acad Sci U S A (1983) 1.49

Developmental expression of neurotypy revealed by immunocytochemistry with monoclonal antibodies. J Neuroimmunol (1982) 1.48

Phosphorylated neurofilament antigens in neurofibrillary tangles in Alzheimer's disease. J Neuropathol Exp Neurol (1986) 1.48

Electron microscopic immunocytochemistry: a review. J Histochem Cytochem (1967) 1.47

Immunocytochemistry of brain-reactive monoclonal antibodies in peripheral tissues. Cell Tissue Res (1983) 1.45

A molecular mechanism for the induction of neurofilament bundling by aluminum ions. J Neurochem (1992) 1.42

Phosphorylation of neurofilaments is altered in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol (1988) 1.40

Age-related white matter atrophy in the human brain. Ann N Y Acad Sci (1992) 1.39

Ultrastructural localization of contractile protein (thrombosthenin) in human platelets using an unlabeled antibody-peroxidase staining technique. J Histochem Cytochem (1971) 1.38

Senile dementia of Alzheimer type: astroglial reaction to extracellular neurofibrillary tangles in the hippocampus. An immunocytochemical and electron-microscopic study. Acta Neuropathol (1982) 1.38

Immunocytochemical localization of rat peripheral nervous system myelin proteins: P2 protein is not a component of all peripheral nervous system myelin sheaths. Proc Natl Acad Sci U S A (1979) 1.28

Association of synapsin I with neuronal cytoskeleton. Identification in cytoskeletal preparations in vitro and immunocytochemical localization in brain of synapsin I. J Biol Chem (1986) 1.28

Blood-brain barrier protein recognized by monoclonal antibody. Proc Natl Acad Sci U S A (1987) 1.27

Alzheimer neurofibrillary tangles contain phosphorylated and hidden neurofilament epitopes. J Neurol Neurosurg Psychiatry (1986) 1.27

Phosphorylation protects neurofilaments against proteolysis. J Neuroimmunol (1987) 1.27

A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanoma. Melanoma Res (2003) 1.24

Distribution of papovavirus, myelin-associated glycoprotein, and myelin basic protein in progressive multifocal leukoencephalopathy lesions. Ann Neurol (1982) 1.23

Immunocytochemical observations on the distribution of myelin-associated glycoprotein and myelin basic protein in multiple sclerosis lesions. Ann Neurol (1980) 1.23

Peripheral neuropathy in globoid cell leukodystrophy (Krabbe's disease). Ultrastructural and histochemical findings. Brain (1969) 1.22

Neurologic complications induced by gold treatment. Arthritis Rheum (1983) 1.21

Multiple sclerosis: reticulum cell sarcoma of the nervous system in a patient treated with immunosuppressive drugs. Eur Neurol (1974) 1.19

Molecular neuroanatomy of human monoamine oxidases A and B revealed by quantitative enzyme radioautography and in situ hybridization histochemistry. Neuroscience (1996) 1.18

Protein-protein interactions in concentrated electrolyte solutions. Biotechnol Bioeng (2002) 1.18

Immunocytochemical localization of P0 protein in Golgi complex membranes and myelin of developing rat Schwann cells. J Cell Biol (1981) 1.18

Progressive supranuclear palsy: extensive neuropil threads in addition to neurofibrillary tangles. Very similar antigenicity of subcortical neuronal pathology in progressive supranuclear palsy and Alzheimer's disease. Acta Neuropathol (1988) 1.17

Pick's disease: an immunocytochemical study of neuronal changes. Monoclonal antibodies show that Pick bodies share antigenic determinants with neurofibrillary tangles and neurofilaments. Acta Neuropathol (1983) 1.16

Ultrasound in dermatology. Part I. High frequency ultrasound. Eur J Dermatol (2000) 1.15

Alzheimer's disease: a description of the structural lesions. Brain Pathol (1991) 1.15

The unlabeled antibody method: comparison of peroxidase-antiperoxidase with avidin-biotin complex by a new method of quantification. J Histochem Cytochem (1986) 1.14

Immunocytochemical method to identify myelin basic protein in oligodendroglia and myelin sheaths of the human nervous system. Ann Neurol (1980) 1.13

Treatment of hypertension with a new beta-blocking agent, pindolol (Visken). Eur J Clin Pharmacol (1973) 1.12

Particle-yield modification in jetlike azimuthal dihadron correlations in Pb-Pb collisions at √s(NN)=2.76 TeV. Phys Rev Lett (2012) 1.11

Transition of immunocytochemistry from an anatomical to a biochemical science: evolution of the concept of neurotypy. Neuroscience (1982) 1.11

Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study. J Am Acad Dermatol (2002) 1.11

Adrenoleukodystrophy. Preliminary report of a connatal case. Light- and electron microscopical, immunohistochemical and biochemical findings. Acta Neuropathol (1978) 1.09

Cerebellar ganglioglioma in a child. J Neuropathol Exp Neurol (1979) 1.08

Transverse momentum distribution and nuclear modification factor of charged particles in p+Pb collisions at sqrt[s(NN)] = 5.02 TeV. Phys Rev Lett (2013) 1.08

Subacute inclusion body encephalitis. A histological and electron microscopical study. Acta Neuropathol (1966) 1.07

Immunocytochemical expression of the endothelial barrier antigen (EBA) during brain angiogenesis. Brain Res Dev Brain Res (1992) 1.07

Deposition of beta/A4 protein along neuronal plasma membranes in diffuse senile plaques. Acta Neuropathol (1991) 1.07

[Peripheral neurological disorders in Fabry's disease (angiokeratoma corporis diffusum universale). Clinical and electron microscopic findings in a case]. Klin Wochenschr (1968) 1.06

[Relations of nerve conduction velocity to histologic findings in peripheral nerves. Based on 49 biopsies of the sural nerve]. Dtsch Z Nervenheilkd (1965) 1.06

Biochemical demonstration of the myelin-associated glycoprotein in the peripheral nervous system. J Neurochem (1981) 1.05

The role of cathepsin D in the pathogenesis of tuberculosis. A histochemical study employing unlabeled antibodies and the peroxidase-antiperoxidase complex. Am J Pathol (1974) 1.05

Quantitative immunocytochemistry of pituitary receptors for luteinizing hormone-releasing hormone. Cell Tissue Res (1975) 1.04

Cell surface endothelial proteins altered in experimental allergic encephalomyelitis. J Neuroimmunol (1989) 1.03

Lewy body dementia without Alzheimer changes. Can J Neurol Sci (1986) 1.03

Neurofilamentous abnormalities in motor neurons in spontaneously occurring animal disorders. J Neuropathol Exp Neurol (1988) 1.03

Schwannoma of the olfactory groove. Case report and review of previous cases. Acta Neurochir (Wien) (1978) 1.02

Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG). Br J Cancer (2001) 1.02

Biochemical identification of the site of action of benzodiazepines in human brain by 3H-diazepam binding. Life Sci (1978) 1.01

The structure of the sialic acid-containing Escherichia coli O104 O-specific polysaccharide and its linkage to the core region in lipopolysaccharide. Carbohydr Res (1992) 1.01

Ultrastructural immunocytochemistry with unlabeled antibodies and the peroxidase-antiperoxidase complex. A technique more sensitive than radioimmunoassay. J Histochem Cytochem (1973) 1.00

Prevalence and heredity of migraine and migrainoid headaches among 461 Danish doctors. Headache (1973) 1.00

The unlabeled antibody (PAP) method, introduction. J Histochem Cytochem (1979) 1.00

Increase of sodium channels in demyelinated lesions of multiple sclerosis. Brain Res (1991) 1.00

Adjuvant low-dose interferon {alpha}2a with or without dacarbazine compared with surgery alone: a prospective-randomized phase III DeCOG trial in melanoma patients with regional lymph node metastasis. Ann Oncol (2008) 0.99

Immunohistological study of granulovacuolar degeneration using monoclonal antibodies to neurofilaments. J Neurol Neurosurg Psychiatry (1985) 0.99

Senile plaque neurites fail to demonstrate anti-paired helical filament and anti-microtubule-associated protein-tau immunoreactive proteins in the absence of neurofibrillary tangles in the neocortex. Acta Neuropathol (1989) 0.99

Leakage and neuronal uptake of serum protein in aged and Alzheimer brains. A postmortem phenomenon with antemortem etiology. Lab Invest (1991) 0.98

Production of muons from heavy flavor decays at forward rapidity in pp and Pb-Pb collisions at sqrt[s(NN)]=2.76  TeV. Phys Rev Lett (2012) 0.98

Distribution of neurofilament antigens after axonal injury. J Neuropathol Exp Neurol (1987) 0.98

Alzheimer dementia and Pick's disease: neurofibrillary tangles and Pick bodies are associated with identical phosphorylated neurofilament epitopes. Acta Neuropathol (1987) 0.97

Abnormal processing of multiple proteins in Alzheimer disease. Proc Natl Acad Sci U S A (1989) 0.97

Ultrastructural localization of TRH-like immunoreactivity. Exp Brain Res (1980) 0.97

Preparation and characterization of antisera to the myelin-associated glycoprotein. Neurochem Res (1981) 0.97

Morphological adaptive response of the synaptic junctional zones in the human dentate gyrus during aging and Alzheimer's disease. Brain Res (1990) 0.95

Amiodarone neuropathy (author's transl). Schweiz Rundsch Med Prax (1976) 0.95

Structure of the catalytic region of human complement protease C1s: study by chemical cross-linking and three-dimensional homology modeling. Biochemistry (1995) 0.95